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Hyper-Insulinemia Euglycemia Therapy (HIET)  






























Low insulin action 
Limited glycemia reduction 
Low exogenous glucose input 
Increased insulin sensitivity Important insulin action  
Patient with low insulin sensitivity Hypoglycemic risk 
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Introduction  Research purpose 
 Empirical therapy 
 Difficult dosing 
 High risk (hypoglycemia) 
 « Last chance » therapy 
 
 Model-based protocol 
 Optimal interventions 
 Tightly controlled glycemia 
 Safe and effective therapy 
 
HIET nowadays HIET in the future 
1) Should the insulin-glucose system model be adapted?  
2) Should the insulin kinetics be modified at high insulin doses? 
3) Is insulin sensitivity decisive for HIET optimisation? 
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Methods  Model 
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Comparison between measured and simulated 𝐼 
Model adaptation 
Results and Discussion 
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Results 
 Comparison between measured and simulated 𝐼 
 
Patient 1 






















Measured > Simulated Lower clearance in the model 
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 Comparison between measured and simulated 𝐼 
 
Patient 2 
Saturation at high insulin levels Higher clearance in the model 
Hypothesis: erroneous measurements 
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 Comparison between measured and simulated 𝐼 
 
Patient 3 
Measured > Simulated Lower clearance in the model 
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Results 
 Comparison between measured and simulated 𝐼 
 
Patient 4 






















Saturation at high insulin levels Higher clearance in the model 
Measured > Simulated Lower clearance in the model 
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Results 
 Unsaturated renal clearance 
• Alternative insulin receptors? 
 Additional clearance process 
• Elimination via urine? 
• Interstitial space storage? 
Mechanisms: 
• Time-dependent? 
• Insulin plasma concentration 
dependent? 
• Insulin exposure dependent? 
• Patient-specific? 
Reduced clearance (0h-10h) Increased clearance (20 > t >10h) 
 Saturated renal clearance 































































































Additional renal process after 15 hours: −0.7 ∗ 𝐼 



























1) Should the insulin-glucose system model be adapted?  YES 
2) Should the insulin kinetics be modified at high insulin doses? YES 
Reduced clearance (0h-10h) Increased clearance (t >10h) 





 Unsaturated renal clearance 
 Additional clearance process 
Initial saturation Body adaptation (t >10h) 
 Inotropic insulin action 




 Large insulin elimination 
 Uneffective therapy 
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Questions? 
Thank you for your attention 
